Grant

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

CountryUnited States
DeadlineNot published
Published2023-11-24
SectorsHealth & life sciences, SME & startup support
SourceGrants.gov (US)

Summary

Funding opportunity FOR-FD-24-007. CFDA: 93.103

The buyer, the value, the full description and the link to the official notice are available with a free account.